| Q73265878 | Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation |
| Q34401823 | Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators? |
| Q36816260 | Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest |
| Q73716475 | Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry |
| Q35531009 | Diagnosis and management of ventricular tachycardia |
| Q44011686 | Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up |
| Q50927327 | Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. |
| Q43549671 | Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction |
| Q36828553 | Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction |
| Q43243086 | Managing ventricular tachyarrhythmias in the developing world: insights from recent ICD trials. |
| Q33544729 | Methods of identifying patients at high risk of subsequent arrhythmic death after myocardial infarction. |
| Q71948926 | Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: Importance of β-blockade |
| Q72609247 | Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction |
| Q35560103 | Strategies for the prevention and treatment of sudden cardiac death |
| Q33688992 | Surgery for postinfarction ventricular tachycardia in the pre-implantable cardioverter defibrillator era: early and long term outcomes in 100 consecutive patients |
| Q68190748 | Sustained ventricular tachyarrhythmias after infarction: when should the worrying begin? |
| Q44905229 | The Patient with Ventricular Arrhythmias Can be Offered Optimal Treatment on the Basis of Simple Clinical Variables |
| Q40485911 | The Rationale for Prophylactic Implantation of a Defibrillator in “High Risk” Patients |
| Q67655529 | The Vaughan-Williams Classification of Antiarrhythmic Drugs. Why Don't We Find its Clinical Counterpart? |
| Q33145900 | Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study |
| Q33151818 | Which ventricular tachycardia is dangerous? |
| Q74603940 | [Current indications for implantable automatic defibrillators] |
| Q73656203 | [Practice guidelines of the Spanish Society of Cardiology on cardiac arrythmias] |